PL2912041T3 - Pochodne tetrahydropirolotiazyny stanowiące inhibitory BACE - Google Patents
Pochodne tetrahydropirolotiazyny stanowiące inhibitory BACEInfo
- Publication number
- PL2912041T3 PL2912041T3 PL13785730T PL13785730T PL2912041T3 PL 2912041 T3 PL2912041 T3 PL 2912041T3 PL 13785730 T PL13785730 T PL 13785730T PL 13785730 T PL13785730 T PL 13785730T PL 2912041 T3 PL2912041 T3 PL 2912041T3
- Authority
- PL
- Poland
- Prior art keywords
- tetrahydropyrrolothiazine
- derivatives
- bace inhibitors
- bace
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261718728P | 2012-10-26 | 2012-10-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2912041T3 true PL2912041T3 (pl) | 2017-06-30 |
Family
ID=49515508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13785730T PL2912041T3 (pl) | 2012-10-26 | 2013-10-17 | Pochodne tetrahydropirolotiazyny stanowiące inhibitory BACE |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9328124B2 (pl) |
| EP (1) | EP2912041B1 (pl) |
| JP (1) | JP6243921B2 (pl) |
| CN (1) | CN104755484B (pl) |
| CA (1) | CA2886507C (pl) |
| CY (1) | CY1118623T1 (pl) |
| DK (1) | DK2912041T3 (pl) |
| ES (1) | ES2616835T3 (pl) |
| HR (1) | HRP20170025T1 (pl) |
| HU (1) | HUE031764T2 (pl) |
| LT (1) | LT2912041T (pl) |
| ME (1) | ME02576B (pl) |
| PL (1) | PL2912041T3 (pl) |
| PT (1) | PT2912041T (pl) |
| RS (1) | RS55561B1 (pl) |
| SI (1) | SI2912041T1 (pl) |
| WO (1) | WO2014066132A1 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2961749B1 (en) | 2013-03-01 | 2019-10-09 | Amgen Inc. | Perfluorinated 5,6-dihydro-4h-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use |
| CA2903215C (en) | 2013-03-08 | 2021-07-20 | Amgen Inc. | Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use |
| TWI684452B (zh) * | 2014-03-14 | 2020-02-11 | 美國禮來大藥廠 | 胺基噻嗪化合物 |
| US9550762B2 (en) | 2014-08-08 | 2017-01-24 | Amgen, Inc. | Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use |
| US10246429B2 (en) | 2015-08-06 | 2019-04-02 | Amgen Inc. | Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use |
| US11021493B2 (en) | 2016-12-15 | 2021-06-01 | Amgen Inc. | 1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use |
| CA3047288A1 (en) | 2016-12-15 | 2018-06-21 | Amgen Inc. | Thiazine derivatives as beta-secretase inhibitors and methods of use |
| EP3555085B1 (en) | 2016-12-15 | 2020-12-02 | Amgen Inc. | Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use |
| EP3555106B1 (en) | 2016-12-15 | 2022-03-09 | Amgen Inc. | Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of use |
| WO2018112081A1 (en) | 2016-12-15 | 2018-06-21 | Amgen Inc. | Oxazine derivatives as beta-secretase inhibitors and methods of use |
| CN106632001A (zh) * | 2016-12-28 | 2017-05-10 | 山东诚汇双达药业有限公司 | 一种4‑（溴乙酰基）吡啶氢溴酸盐的制备方法 |
| CN110452179A (zh) * | 2019-06-25 | 2019-11-15 | 南京普锐达医药科技有限公司 | 一种2-氯-4-甲氧基-5-氰基嘧啶的合成方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR054617A1 (es) * | 2005-06-14 | 2007-07-04 | Schering Corp | Derivados de pirrol[3, 4 - d]pirimidina como inhibidores de aspartil proteasas y composiciones farmacéuticas que los comprenden |
| US8653067B2 (en) | 2007-04-24 | 2014-02-18 | Shionogi & Co., Ltd. | Pharmaceutical composition for treating Alzheimer's disease |
| KR101564634B1 (ko) * | 2008-01-18 | 2015-10-30 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 축합 아미노디하이드로 티아진 유도체 |
| TW201004957A (en) | 2008-04-22 | 2010-02-01 | Schering Corp | Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use |
| US8637504B2 (en) | 2008-06-13 | 2014-01-28 | Shionogi & Co., Ltd. | Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity |
| TW201016708A (en) | 2008-09-30 | 2010-05-01 | Eisai R&D Man Co Ltd | Novel fused aminodihydrothiazine derivative |
| AR077277A1 (es) * | 2009-07-09 | 2011-08-17 | Lilly Co Eli | Compuestos de biciclo (1,3)tiazin-2-amina formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento util para el tratamiento de la enfermedad de alzheimer |
| GB0912778D0 (en) * | 2009-07-22 | 2009-08-26 | Eisai London Res Lab Ltd | Fused aminodihydro-oxazine derivatives |
| WO2011071109A1 (ja) * | 2009-12-11 | 2011-06-16 | 塩野義製薬株式会社 | アミノ基を有する縮合ヘテロ環化合物 |
| GB201100181D0 (en) | 2011-01-06 | 2011-02-23 | Eisai Ltd | Fused aminodihydrothiazine derivatives |
| WO2012162334A1 (en) | 2011-05-24 | 2012-11-29 | Bristol-Myers Squibb Company | Compounds for the reduction of beta-amyloid production |
| JO3143B1 (ar) | 2012-04-03 | 2017-09-20 | Lilly Co Eli | مركبات تتراهيدرو بيرولو ثيازين |
| GB201212871D0 (en) | 2012-07-20 | 2012-09-05 | Eisai Ltd | Novel compounds |
| TWI593692B (zh) | 2013-03-12 | 2017-08-01 | 美國禮來大藥廠 | 四氫吡咯并噻嗪化合物 |
-
2013
- 2013-10-17 CA CA2886507A patent/CA2886507C/en not_active Expired - Fee Related
- 2013-10-17 DK DK13785730.6T patent/DK2912041T3/en active
- 2013-10-17 PL PL13785730T patent/PL2912041T3/pl unknown
- 2013-10-17 PT PT137857306T patent/PT2912041T/pt unknown
- 2013-10-17 RS RS20170016A patent/RS55561B1/sr unknown
- 2013-10-17 HU HUE13785730A patent/HUE031764T2/en unknown
- 2013-10-17 CN CN201380055699.5A patent/CN104755484B/zh not_active Expired - Fee Related
- 2013-10-17 SI SI201330463T patent/SI2912041T1/sl unknown
- 2013-10-17 JP JP2015539666A patent/JP6243921B2/ja not_active Expired - Fee Related
- 2013-10-17 LT LTEP13785730.6T patent/LT2912041T/lt unknown
- 2013-10-17 EP EP13785730.6A patent/EP2912041B1/en active Active
- 2013-10-17 ES ES13785730.6T patent/ES2616835T3/es active Active
- 2013-10-17 US US14/427,648 patent/US9328124B2/en not_active Expired - Fee Related
- 2013-10-17 WO PCT/US2013/065418 patent/WO2014066132A1/en active Application Filing
-
2017
- 2017-01-10 HR HRP20170025TT patent/HRP20170025T1/hr unknown
- 2017-02-10 ME MEP-2017-4A patent/ME02576B/me unknown
- 2017-02-10 CY CY20171100191T patent/CY1118623T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014066132A1 (en) | 2014-05-01 |
| SI2912041T1 (sl) | 2017-02-28 |
| CN104755484B (zh) | 2016-02-17 |
| EP2912041B1 (en) | 2016-12-14 |
| CA2886507A1 (en) | 2014-05-01 |
| LT2912041T (lt) | 2017-03-10 |
| CA2886507C (en) | 2016-09-20 |
| PT2912041T (pt) | 2017-02-13 |
| JP6243921B2 (ja) | 2017-12-06 |
| RS55561B1 (sr) | 2017-05-31 |
| ES2616835T3 (es) | 2017-06-14 |
| JP2015535247A (ja) | 2015-12-10 |
| CN104755484A (zh) | 2015-07-01 |
| US9328124B2 (en) | 2016-05-03 |
| HUE031764T2 (en) | 2017-07-28 |
| HRP20170025T1 (hr) | 2017-03-10 |
| EP2912041A1 (en) | 2015-09-02 |
| CY1118623T1 (el) | 2017-07-12 |
| US20150232483A1 (en) | 2015-08-20 |
| ME02576B (me) | 2017-06-20 |
| DK2912041T3 (en) | 2017-02-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2200040I1 (hu) | Benzimidazol-prolin származékok | |
| HRP20181429T1 (hr) | Novi derivati benzimidazola kao inhibitori kinaze | |
| HK1210775A1 (en) | Imidazotriazinecarbonitriles useful as kinase inhibitors | |
| HK1208442A1 (en) | Substituted pyrrolopyrimidinylamino-benzothiazolones as mknk kinase inhibitors mknk | |
| ME02576B (me) | Derivati tetrahidropirolotiazina kao inhibitori bace | |
| HK1205740A1 (en) | Pyrrolotriazinone derivatives | |
| EP2934534A4 (en) | C5-SPIRO-IMINOTHIADIAZINDIOXIDES AS BACE INHIBITORS | |
| SG11201500973WA (en) | Amino-quinolines as kinase inhibitors | |
| EP2934149A4 (en) | C6-AZASPIRO-IMINOTHIADIAZINDIOXIDES AS BACE INHIBITORS | |
| ZA201502175B (en) | Oxazolidin-2-one-pyrimidine derivatives | |
| HK1206350A1 (en) | 2h-imidazol-4-amine compounds and their use as bace inhibitors 2h--4- bace | |
| EP2922543A4 (en) | SUBSTITUTED PYRIDONE DERIVATIVES AS PDE10 INHIBITORS | |
| SG11201404325VA (en) | Pyrimidooxazocine derivatives as mtor - inhibitors |